Vinod Ravi

12PUBLICATIONS
70CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markersSocial epidemiologyContext learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 26, 2026
Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.

|Sep 17, 2024
MANEUVER: A Phase III study of pimicotinib to assess efficacy and safety in tenosynovial giant cell tumor patients.

Xiaohui Niu, Vinod Ravi, Boyao Shan

|Mar 01, 2024
Phase II Trial of nab-Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update.

Andrew J Wagner, Vinod Ravi, Richard F Riedel

|Dec 08, 2023
COVID-19 in cancer patients: The impact of vaccination on outcomes early in the pandemic.

Fareed Khawaja, Georgios Angelidakis, Adina Feldman

|Jun 01, 2023
Incidence, demographics, and survival of malignant hemangioendothelioma in the United States.

Kelly G Paulson, Vinod Ravi, Brian P Rubin

|Apr 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).

Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik

Pageof 2

Frequent Collaborators

5 joint publications

Neeta Somaiah

4 joint publications

Shreyaskumar R Patel

4 joint publications

Robert S Benjamin

3 joint publications

Andrew J Wagner